ThuLEP

ThuLEP (Thulium Laser Enucleation of the Prostate) is a minimally invasive surgical procedure used to treat benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland. This technique involves the use of a Thulium laser to enucleate (remove) the obstructive prostate tissue, alleviating symptoms associated with BPH such as urinary retention, weak urine flow, and frequent urination.

• Anesthesia: The procedure is typically performed under general or spinal anesthesia.
• Laser Enucleation: A Thulium laser is used to precisely cut and remove the enlarged prostate tissue. The laser's wavelength is well-suited for cutting and coagulating soft tissue, providing effective hemostasis (control of bleeding).
• Morcellation: After enucleation, the excised tissue is morcellated (cut into smaller pieces) within the bladder and then removed.

• Minimally Invasive: ThuLEP is less invasive compared to traditional open or even some minimally invasive surgeries.
• Reduced Bleeding: The Thulium laser provides excellent control over bleeding, reducing the need for blood transfusions.
• Shorter Hospital Stay: Patients typically experience a quicker recovery and shorter hospital stays.
• Effective Symptom Relief: Significant and long-lasting relief from BPH symptoms is achieved.
• Preservation of Sexual Function: There is a lower risk of sexual dysfunction compared to some other surgical options.

• Urinary Incontinence: There is a risk of temporary or, in rare cases, permanent urinary incontinence.
• Urinary Tract Infections (UTIs): Postoperative UTIs can occur.
• Urethral Stricture: There is a risk of narrowing of the urethra.

• Catheterization: A catheter is usually placed for a short period to aid in urine drainage post-surgery.
• Hydration: Patients are encouraged to drink plenty of fluids to flush out the bladder.
• Activity: Light activities are recommended initially, with gradual return to normal activities.